Medical Data Vision Co Ltd
TSE:3902
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
463
836
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Medical Data Vision Co Ltd
Intrinsic Value
Medical Data Vision Co., Ltd. engages in the development, production, sales, and maintenance of integrated medical information systems. [ Read More ]
The intrinsic value of one
Medical Data Vision Co Ltd
stock under the Base Case scenario is
866.42
JPY.
Compared to the current market price of 538 JPY,
Medical Data Vision Co Ltd
is
Undervalued by 38%.
Medical Data Vision Co Ltd's market capitalization is 20.5B JPY.
Medical Data Vision Co Ltd stock price is 538 JPY.
Medical Data Vision Co Ltd stock price (538 JPY) is 38% less than its Intrinsic Value (866.42 JPY).
Medical Data Vision Co Ltd stock price (538 JPY) is 38% less than its DCF Value (870.39 JPY). Open DCF Valuation
Medical Data Vision Co Ltd stock price (538 JPY) is 38% less than its Relative Value (862.45 JPY). Open Relative Valuation
Medical Data Vision Co Ltd has upside potential of 35% compared to the average analyst price target.
Open Wall St Estimates
Medical Data Vision Co Ltd's Revenue has grown by 2% over the past 12 months.
Medical Data Vision Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 23% to 18%.
Medical Data Vision Co Ltd has positive Net Income for the last twelve months.
Medical Data Vision Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 18%.
Medical Data Vision Co Ltd's Revenue has been growing by 8% per year for the last 3 years.
Medical Data Vision Co Ltd's Revenue is forecast to grow at a rate of 15% per year over the next 3 years.
Medical Data Vision Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 27%.
Medical Data Vision Co Ltd has positive Operating Income for the last twelve months.
Medical Data Vision Co Ltd's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 50% to 27%.
Medical Data Vision Co Ltd has positive three-year average ROE (Return on Equity): 25%. The company is efficient at transforming stockholders' equity into net income.
Medical Data Vision Co Ltd has positive Free Cash Flow for the last twelve months.
Medical Data Vision Co Ltd has positive Gross Profit for the last twelve months.
Medical Data Vision Co Ltd's short-term assets (4B JPY) exceed its short-term liabilties (1B JPY).
Medical Data Vision Co Ltd's long-term assets (6B JPY) exceed its long-term liabilties (2B JPY).
Medical Data Vision Co Ltd has very high three-year average ROIC (Return on Invested Capital): 45%. The company is very efficient at using invested capital to generate operating income.
Medical Data Vision Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.
Medical Data Vision Co Ltd's Altman Z-Score is very high and is equal to 11.21.
Valuation Backtest
Medical Data Vision Co Ltd
Run backtest to discover the historical profit from buying and selling
Medical Data Vision Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Medical Data Vision Co Ltd
| Current Assets | 4B |
| Cash & Short-Term Investments | 2.9B |
| Receivables | 811.7m |
| Other Current Assets | 343.3m |
| Non-Current Assets | 1.6B |
| Long-Term Investments | 654.5m |
| PP&E | 260.4m |
| Intangibles | 84.3m |
| Other Non-Current Assets | 624.2m |
| Current Liabilities | 1.5B |
| Accounts Payable | 123.2m |
| Accrued Liabilities | 11.7m |
| Other Current Liabilities | 1.3B |
| Non-Current Liabilities | 173.6m |
| Other Non-Current Liabilities | 173.6m |
Earnings Waterfall
Medical Data Vision Co Ltd
|
Revenue
|
6.2B
JPY
|
|
Cost of Revenue
|
-1.4B
JPY
|
|
Gross Profit
|
4.8B
JPY
|
|
Operating Expenses
|
-3.6B
JPY
|
|
Operating Income
|
1.3B
JPY
|
|
Other Expenses
|
-580.4m
JPY
|
|
Net Income
|
688m
JPY
|
Free Cash Flow Analysis
Medical Data Vision Co Ltd
| JPY | |
| Free Cash Flow | JPY |
Profitability Score
Profitability Due Diligence
Medical Data Vision Co Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
Score
Medical Data Vision Co Ltd's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Medical Data Vision Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Score
Medical Data Vision Co Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Medical Data Vision Co Ltd
According to Wall Street analysts, the average 1-year price target for
Medical Data Vision Co Ltd
is 724.2 JPY
with a low forecast of 717.1 JPY and a high forecast of 745.5 JPY.
Click here to dive deeper.
Price Appreciation
Price
Medical Data Vision Co Ltd
| Average Annual Return | 36.54% |
| Standard Deviation of Annual Returns | 148.77% |
| Max Drawdown | -86% |
| Market Capitalization | 20.5B JPY |
| Shares Outstanding | 38 196 848 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Medical Data Vision Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Medical Data Vision Co., Ltd. engages in the development, production, sales, and maintenance of integrated medical information systems. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 245 full-time employees. The company went IPO on 2014-12-16. is a company engaged in the medical data network business. The Data Network Service provides management support systems for medical institutions and health insurance unions, as well as EVE, Medical Code and CADA-BOX for hospitals. The Data Utilization Service provides corporate services and personal services based on the medical and health information accumulated through the data network services, various analysis data to pharmaceutical companies, research institutes, patients and consumers. The segment provides various services, such as MDV analyzer, ADHOC research service, OTC, H&BC and insurance company services, as well as Media logs and others.
Contact
IPO
Employees
Officers
The intrinsic value of one
Medical Data Vision Co Ltd
stock under the Base Case scenario is
866.42
JPY.
Compared to the current market price of 538 JPY,
Medical Data Vision Co Ltd
is
Undervalued by 38%.
You don't have any saved screeners yet
